See the Complete Picture.
Published loading...Updated

Drug Used by Trump Has Suicide Risk; FDA's 'Aggressive' AI Rollout; 1K Measles Cases

  • On Thursday, the European Medicines Agency’s safety committee recognized suicidal ideation as a potential adverse effect associated with finasteride tablets used within the European Union.
  • This confirmation came after a review initiated in October 2024 by the EMA’s safety committee, following a UK alert and concerns raised by patients about potential psychiatric side effects.
  • Most reported cases of suicidal ideation involved 1 mg finasteride tablets for male hair loss, while the EMA found insufficient evidence linking dutasteride to these effects.
  • The EMA plans to include a patient card with 1 mg finasteride packaging to inform users about potential risks and appropriate actions, while also updating dutasteride’s product details to incorporate mood change warnings, highlighting the importance of seeking medical advice if symptoms arise.
  • Despite safety concerns, the EMA stated that benefits of finasteride and dutasteride outweigh risks for approved uses but urged healthcare providers to counsel patients for informed decisions.
Insights by Ground AI
Does this summary seem wrong?

13 Articles

All
Left
1
Center
2
Right
1
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medscape broke the news in United States on Friday, May 9, 2025.
Sources are mostly out of (0)

Similar News Topics